HNF4A is a ligand-binding transcriptional regulator that controls hepatic gene expression and maintains metabolic homeostasis across multiple tissues 1. In hepatocytes, HNF4A recruits RNA polymerase II to target gene promoters and represses CLOCK-BMAL1 activity, essential for circadian rhythm regulation 12. HNF4A exhibits tissue-specific functions: in human proximal tubules, it directly regulates transport, endocytosis, and brush border genes critical for electrolyte reabsorption 3, while in pancreatic beta cells and hepatocytes, it binds and regulates distinct gene sets including metabolic regulators and HAAO 4. Loss-of-function HNF4A variants cause maturity-onset diabetes of the young (MODY1), characterized by reduced penetrance (32-98% depending on clinical setting) 56. Type 2 diabetes-associated variants like rs1800961 alter DNA-binding affinity and transcriptional outcomes 47. HNF4A also associates with neuroendocrine carcinomas, defining a distinct molecular subtype with gastrointestinal characteristics 8. Therapeutically, HNF4A mRNA delivery via lipid nanoparticles restores hepatocyte function and attenuates liver fibrosis through paraoxonase 1-mediated mechanisms 9. These findings establish HNF4A as a pleiotropic regulator with precision medicine implications for monogenic and metabolic diseases.